This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Ciscio Bioassays, National Institute of Health and Medical Research. Active years: 2025.
Company Filing History:
1 out of 5,383 
1 out of 1 
1 out of 1,853 
Years Active: 2025
Title: The Innovations of Patrick J M Chames
Introduction
Patrick J M Chames is a notable inventor based in Marseille, France. He has made significant contributions to the field of biotechnology, particularly in the development of single-domain antibodies. His work has implications for various applications in medical research and therapeutic development.
Latest Patents
One of his key patents is a single-domain antibody binding to the G protein alpha. This invention relates to a single-domain antibody (sdAb) that binds to the G protein alpha, comprising an amino acid sequence consisting of three CDR regions (CDR1 to CDR3) and four hinge regions (FR1 to FR4). The formula for this invention is FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4 (I), and it advantageously has a dissociation constant (Kd), measured in FRET, of less than 100 nM. This patent highlights his innovative approach to antibody design and its potential applications in therapeutic settings.
Career Highlights
Throughout his career, Patrick J M Chames has worked with prominent organizations such as Ciscio Bioassays and the Centre National De La Recherche Scientifique. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Thomas Fabien Michel Roux and Elodie Julie Dupuis. Their collaborative efforts have further advanced the research and development of innovative biotechnological solutions.
Conclusion
Patrick J M Chames is a distinguished inventor whose work in single-domain antibodies has the potential to impact the field of biotechnology significantly. His contributions reflect a commitment to advancing medical research and therapeutic applications.